SPART-AS1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SPART-AS1 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SPART-AS1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SPART-AS1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated SPART-AS1 expression acts as an unfavorable survival marker.

LUAD are the cancer types where SPART-AS1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LUADOSMedianAll0.4731.000.0402view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

SPART-AS1–LUAD (OS)

Kaplan–Meier survival curve for SPART-AS1 mass-spec protein-high vs -low samples in LUAD.

Open the LUAD breakdown →

Exploration